Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17,255,853
-
Total 13F shares
-
13,356,680
-
Share change
-
+13,245,976
-
Total reported value
-
$79,068,510
-
Price per share
-
$5.92
-
Number of holders
-
119
-
Value change
-
+$78,413,159
-
Number of buys
-
116
Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q4 2023
As of 31 Dec 2023,
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,356,680 shares.
The largest 10 holders included
WESTFIELD CAPITAL MANAGEMENT CO LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Alta Fundamental Advisers LLC, Newtyn Management, LLC, Prosight Management, LP, Bank of New York Mellon Corp, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.